UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 184

Sortiert nach

Sex differences in immune responses

Science (American Association for the Advancement of Science), 2021-01, Vol.371 (6527), p.347-348

2021

Volltextzugriff (PDF)

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Journal of dermatology, 2019-11, Vol.46 (11), p.1006-1013

2019

Volltextzugriff (PDF)

Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency

Journal of investigative dermatology, 2017-09, Vol.137 (9), p.1850-1859

2017

Volltextzugriff (PDF)

Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis

Rheumatology (Oxford, England), 2020-08, Vol.59 (8), p.2005-2015

2020

Volltextzugriff (PDF)

Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis

Journal of rheumatology, 2017-08, Vol.44 (8), p.1198

2017

Volltextzugriff (PDF)

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study

Journal of dermatology, 2018-12, Vol.45 (12), p.1425-1433

2018

Volltextzugriff (PDF)

Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis

Rheumatology (Oxford, England), 2015-07, Vol.54 (7), p.1308-1316

2015

Volltextzugriff (PDF)

Progranulin Overproduction Due to Fli‐1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2015-12, Vol.67 (12), p.3245-3255

2015

Volltextzugriff (PDF)

Serum angiopoietin‐2 level as a potential biomarker in psoriasis vulgaris

Journal of dermatology, 2017-02, Vol.44 (2), p.205-206

2017

Volltextzugriff (PDF)

Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis

Journal of dermatological science, 2019-01, Vol.93 (1), p.24-32

2019

Volltextzugriff (PDF)

A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis

Experimental dermatology, 2015-02, Vol.24 (2), p.127-132

2015

Volltextzugriff (PDF)

Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis

Archives of Dermatological Research, 2014-05, Vol.306 (4), p.331-338

2014

Volltextzugriff (PDF)

Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis

Journal of dermatology, 2020-06, Vol.47 (6), p.609-614

2020

Volltextzugriff (PDF)

A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis

Experimental dermatology, 2016-04, Vol.25 (4), p.287-292

2016

Volltextzugriff (PDF)

Possible pro‐inflammatory role of heparin‐binding epidermal growth factor‐like growth factor in the active phase of systemic sclerosis

Journal of dermatology, 2018-02, Vol.45 (2), p.182-188

2018

Volltextzugriff (PDF)

A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis

Archives of Dermatological Research, 2017-12, Vol.309 (10), p.833-842

2017

Volltextzugriff (PDF)

A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis

PloS one, 2012-02, Vol.7 (2), p.e32272-e32272

2012

Volltextzugriff (PDF)

Successful treatment with rituximab in a Japanese patient with systemic sclerosis‐associated interstitial lung disease resistant to oral steroid and cyclophosphamide

Journal of dermatology, 2018-06, Vol.45 (6), p.e140-e141

2018

Volltextzugriff (PDF)

Scleroderma en coup de sabre with recurrent episodes of brain hemorrhage

Journal of dermatology, 2016-02, Vol.43 (2), p.203-206

2016

Volltextzugriff (PDF)

Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis

Journal of dermatology, 2015-05, Vol.42 (5), p.524-527

2015

Volltextzugriff (PDF)

Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment

Journal of dermatology, 2015-10, Vol.42 (10), p.1029-1030

2015

Volltextzugriff (PDF)

Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis

Journal of dermatology, 2016-08, Vol.43 (8), p.912-918

2016

Volltextzugriff (PDF)

Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis

Journal of dermatology, 2016-07, Vol.43 (7), p.808-810

2016

Volltextzugriff (PDF)

A case of scleredema adultorum successfully treated with narrow-band ultraviolet B phototherapy

Modern rheumatology, 2016-01, Vol.26 (2), p.302-306

2016

Volltextzugriff (PDF)

Serum H‐ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis

Journal of dermatology, 2017-10, Vol.44 (10), p.1168-1171

2017

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Aktive Filter

ThemaOncology

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(184)

Sprache

Englisch
(173)
Japanisch
(72)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sex differences in immune responses

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency

Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis

Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study

Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis

Progranulin Overproduction Due to Fli‐1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis

Serum angiopoietin‐2 level as a potential biomarker in psoriasis vulgaris

Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis

A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis

Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis

Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis

A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis

Possible pro‐inflammatory role of heparin‐binding epidermal growth factor‐like growth factor in the active phase of systemic sclerosis

A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis

A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis

Successful treatment with rituximab in a Japanese patient with systemic sclerosis‐associated interstitial lung disease resistant to oral steroid and cyclophosphamide

Scleroderma en coup de sabre with recurrent episodes of brain hemorrhage

Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis

Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment

Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis

Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis

A case of scleredema adultorum successfully treated with narrow-band ultraviolet B phototherapy

Serum H‐ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis

Aktive Filter

Suchergebnisse filtern